Description
Used in the treatment of:
- Metastatic colorectal cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Glioblastoma
- Renal cell carcinoma
Bevacizumab blocks VEGF, inhibiting tumor blood vessel formation and restricting cancer cell growth and metastasis.


